Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth C Anderson

Showing results (201-210 of 868) with videos related to

Pageof 87
Sort By:
Autophagy|December 11, 2012
Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cellsMichele Cea, Antonia Cagnetta, Franco Patrone, et al.
Leukemia|August 21, 2019
BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8<sup>+</sup> cytotoxic T lymphocytes against multiple myeloma: clinical applicationsJooeun Bae, Neha Parayath, Wenxue Ma, et al.
Leukemia|January 18, 2020
Correction: BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8<sup>+</sup> cytotoxic T lymphocytes against multiple myeloma: clinical applicationsJooeun Bae, Neha Parayath, Wenxue Ma, et al.
Current Drug Targets|November 1, 2006
Proteasome inhibition as a new therapeutic principle in hematological malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Blood|March 6, 2002
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Future Oncology (London, England)|August 10, 2019
Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologicsKenneth C Anderson, Ola Landgren, Rebecca C Arend, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Body mass index, physical activity, and risk of multiple myelomaBrenda M Birmann, Edward Giovannucci, Bernard Rosner, et al.
Essays in Biochemistry|October 28, 2005
Proteasome inhibitors as therapeuticsConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Expert Review of Anticancer Therapy|July 9, 2005
Proteasome inhibition as a therapeutic strategy for hematologic malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Biomaterials|August 12, 2025
Cancer vaccines: Discovery, development, and challenges for clinical translationZhongkun Zhang, Siyu Yao, Yufei Wang, et al.
Pageof 87

Showing results (201-210 of 868) with videos related to

Sort By:
Pageof 87
Autophagy|December 11, 2012
Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cellsMichele Cea, Antonia Cagnetta, Franco Patrone, et al.
Leukemia|August 21, 2019
BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8<sup>+</sup> cytotoxic T lymphocytes against multiple myeloma: clinical applicationsJooeun Bae, Neha Parayath, Wenxue Ma, et al.
Leukemia|January 18, 2020
Correction: BCMA peptide-engineered nanoparticles enhance induction and function of antigen-specific CD8<sup>+</sup> cytotoxic T lymphocytes against multiple myeloma: clinical applicationsJooeun Bae, Neha Parayath, Wenxue Ma, et al.
Current Drug Targets|November 1, 2006
Proteasome inhibition as a new therapeutic principle in hematological malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Blood|March 6, 2002
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
Future Oncology (London, England)|August 10, 2019
Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologicsKenneth C Anderson, Ola Landgren, Rebecca C Arend, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Body mass index, physical activity, and risk of multiple myelomaBrenda M Birmann, Edward Giovannucci, Bernard Rosner, et al.
Essays in Biochemistry|October 28, 2005
Proteasome inhibitors as therapeuticsConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Expert Review of Anticancer Therapy|July 9, 2005
Proteasome inhibition as a therapeutic strategy for hematologic malignanciesConstantine S Mitsiades, Nicholas Mitsiades, Teru Hideshima, et al.
Biomaterials|August 12, 2025
Cancer vaccines: Discovery, development, and challenges for clinical translationZhongkun Zhang, Siyu Yao, Yufei Wang, et al.
Pageof 87